A pilot randomized study of smokeless tobacco use among smokers not interested in quitting: Changes in smoking behavior and readiness to quit
Authors:
- Matthew J. CarpenterMCMatthew J. Carpenter
- Kevin M. GrayKGKevin M. Gray
- 6 January 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Nicotine & Tobacco Research
- Vol. 12 (2) , 136-143
Abstract
Several prior studies suggest that smokeless tobacco use results in less carcinogenic risk than does cigarette smoking. Whether smokers will use smokeless tobacco is unclear, as is the impact of such use on long-term smoking behavior and cessation. It is equally plausible that smokeless tobacco use among smokers could either (a) increase total tobacco exposure and undermine motivation to quit or (b) decrease overall tobacco exposure, motivate smokers to quit, and enhance cessation. Either outcome is of major public health significance. In this small (N = 31), short-term (2 week) pilot study, smokers uninterested in quitting were randomized to (a) receive Ariva or Stonewall (both spitless and smokeless tobacco lozenges) or (b) continue smoking conventional cigarettes. Ariva/Stonewall use led to a significant reduction (40%, 95% CI: 24%–55%) in cigarettes per day, no significant increases in total tobacco use (cigarettes + Ariva/Stonewall; p > .05), and significant increases in two measures of readiness to quit, either in the next month (p < .001) or within the next 6 months (p = .04), as well as significant increases in self-efficacy to quit smoking (p < .001). No such changes were found among smokers maintained on conventional cigarettes. These results suggest no deleterious effect on short-term smoking and quitting behavior among smokers who use smokeless tobacco. More broadly, this study suggests a strong need for a large prospective randomized clinical trial to more accurately assess the long-term viability of smokeless tobacco use as a method for cessation induction among unmotivated smokers.Keywords
This publication has 46 references indexed in Scilit:
- Quitting cigarettes completely or switching to smokeless tobacco: do US data replicate the Swedish results?Tobacco Control, 2009
- Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokersNicotine & Tobacco Research, 2008
- Snus use and other correlates of smoking cessation in the Swedish Twin RegistryPsychological Medicine, 2007
- Impact of corrective health information on consumers' perceptions of "reduced exposure" tobacco productsTobacco Control, 2007
- Nicotine pharmacokinetics and subjective effects of three potential reduced exposure products, moist snuff and nicotine lozengeTobacco Control, 2007
- Carboxyhemoglobin and thiocyanate as biomarkers of exposure to carbon monoxide and hydrogen cyanide in tobacco smokeExperimental and Toxicologic Pathology, 2006
- Tobacco‐specific nitrosamines in new tobacco productsNicotine & Tobacco Research, 2006
- The Fagerström Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance QuestionnaireBritish Journal of Addiction, 1991
- Measuring processes of change: Applications to the cessation of smoking.Journal of Consulting and Clinical Psychology, 1988
- Longitudinal data analysis using generalized linear modelsBiometrika, 1986